Medication incidents that could have been prevented at the prescribing stage

1222

Systems-based vulnerabilities are reflected in the volume and type of medication errors, and anonymous reporting demonstrates a commitment to an open culture of sharing and quality improvement by healthcare professionals. For a patient, a medication error can range from a near-miss to patient death, with varying degrees of severity in between. The prescribing stage represents the patient’s first contact within the medication-use process and is an important milestone in helping to guide patients to positive outcomes and better health. Thus, to be able to definitively address and prevent patient harm, Canada conducted a multi-incident analysis focusing on the prescribing stage of the medication-use process to highlight potential areas for improvement.

Incidents were retrieved from ISMP Canada’s Community Pharmacy Incident Reporting (CPhIR) program from the period between January 2010 and April 2015. Inclusion criteria included all levels of harm to patients with the exception of “No Error”. The decision to exclude data from hospital reporting programs allowed ISMP Canada to gain an understanding of the more broad prescribing landscape of the community setting, which expands our exposure to medication errors in a non-formulary-limited prescribing environment. A total of 2 main themes and 7 subthemes were identified by this analysis.

Therapeutic Plan Error

Therapeutic plan error refers to medication incidents that occurred during the prescribing stage as a result of any therapeutic oversight of a patient’s pharmacotherapy plan. The four subthemes that fall under this category include Incorrect Dose, Medication Discrepancy, Allergy, and Drug-Drug Interactions. A prescriber’s intentions are not always clearly outlined, and there is a lack of a standardized format for prescribers to confirm recommendations or aspects regarding dose appropriateness. These issues highlight the need for a readily-available, comprehensive medical information platform for healthcare professionals to refer to when prescribing medications. Any gap in patient medication history knowledge lends itself to mistakes being made at all stages of the medication-use process, with the prescribing stage acting as the initial onset for this cascading effect. Recommendations based on the hierarchy of effectiveness and best medication practices are outlined in Table 1.

Table 1. Recommendations to prevent Therapeutic Plan Errors

Subtheme Contributing Factors Recommendations
Incorrect Dose Lack of process to confirm recommendations or therapy appropriateness Use standardized order sets

 

Increase access to therapeutic information resources

 

Patient education on signs and symptoms of over/under-dosing of medications

Medication Discrepancy Lack of appropriate clinical decision support system

 

Alert fatigue

 

Lack of relevant patient information

Implement user-friendly clinical decision support system

 

Check-point barriers for high-risk alerts

 

Utilize mandatory data entry fields when gathering information from patients

 

Conduct Best Possible Mediation History (BPMH) during initial interaction with patients

 

Involvement of patients and caregivers to ensure compliance of medication therapy

Allergy
Drug-Drug Interactions

 

Therapeutic Plan Execution Error

The second main theme of this multi-incident analysis was therapeutic plan execution error which refers to mediation incidents that occurred due to the technical aspects of the prescribing stage. This includes subthemes such as Incomplete Prescription, Illegible Writing, and Wrong Patient. With the multitude of drug products on the current market, there is an increased need for vigilance when providing prescriptions to patients. Although the technical aspects of a prescription are often overlooked as minor issues, occurrences still have the potential to cause severe patient harm. The implementation of computerized physician order entry (CPOE) systems remains a powerful tool to help prescribers prevent medication errors. Recommendations based on the hierarchy of effectiveness and best medication practices are outlined in Table 2.

Table 2. Recommendations to prevent Therapeutic Plan Execution Errors

Subtheme Contributing Factors Recommendations
Incomplete Prescription Lack of forcing functions/reminders for data entry fields Utilize CPOE systems with mandatory prescription fields*

 

Utilize pre-printed order sets

 

Independent double checks

 

Staff education regarding

mandatory prescription data entry fields

 

Illegible Writing Lack of process to ensure prescription legibility Utilize CPOE systems*

 

Incorporate process for ensuring prescription legibility before providing prescription to patient

 

Wrong Patient Lack of process to confirm patient identity Alerts for similar patient profiles

 

Utilize two separate patient identifiers at each stage of the medication-use process

 

*CPOE systems may introduce other safety challenges in the medication use process. Therefore, always assess the risks versus benefits of using a new system in the workplace/workflow before widespread implementation.

Prescribers currently have more point-of-care tools or resources at their disposal than ever before and the opportunities to mitigate patient harm are vast. The proper use of clinical decision support systems and order entry sets can help overcome the therapeutic and technical limitations of prescribing, helping prescribers achieve their desired and optimal patient outcome.